SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (8766)5/2/2001 1:52:11 PM
From: Vector1  Respond to of 9719
 
Thanks Tuck, ABSC has a ton of proprietary technology that goes well beyond UHTSS and green florensent protien. The question was how will they leverage off the technolgy. However, I have always viewed VRTX as a rational drug design shop and not a high throughput muscle operation. My guess is that ABSC has developed some highly proprietary screening assays and techniques that work well with VRTX's drug development program.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News